Study the Prevalence of Multidrug resistant bacteria from air samples collected from Mumbai & Suburban areas

Abstract

Abstract Introduction: Air comprises mixture of airborne bacteria & air pollutants in near surface of atmosphere. Air pollution is one of the major threat around the world due to change in physical and chemical parameters because of natural and anthropogenic activities; leading to climate change. Materials and Methods: A systematic analysis of AQI included air pollutants PM2.5, PM10, CO, SO2, NO2, O3, NH3 using SAMEER app developed by CPCB and meteorological parameters including wind speed and relative humanity. The overuse of antibiotics since last two decades has lead pathogenic bacteria gaining resistance. Results: The study was carried out to identify the prevalence of MDR bacteria in air from 8 different spatial variations of Mumbai & Suburban areas. 32 isolates from air were collected by settle plate technique. Enumeration and characterization of bacteria was performed. Antibiotic susceptibility test against 10 antibiotics; test showed that all bacterial isolates were sensitive to Tigecycline. The bacteria were highly resistant to Methicillin by 81.25 %. ARI of two isolates was 0.9 & MRI of Vasai, 0.625 was the highest. The prominent pollutant among 8 locations was found to be PM2.5, CO & PM10. PCA & hierarchical cluster analysis showed that MRI is not correlated to 8 parameters but, distinctly related to NH3. Conclusions: The MDR bacteria travel from soil, plants, water, humans, places, inanimate objects into the air. Hence, it is necessary to maintain the sanitation, ecological balance & usage of antibiotics when necessary.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present work are contained in the manuscript

留言 (0)

沒有登入
gif